Abstract:IMPORTANCE Evidence on the timing of fetal growth alterations associated with gestational diabetes or on the association of the maternal glycemic trajectory with fetal growth during pregnancy remains lacking. OBJECTIVE To examine the associations between maternal glucose levels and offspring intrauterine growth. DESIGN, SETTING, AND PARTICIPANTS This cohort study used data from 4574 eligible pregnant women and their offspring in the Shanghai Maternal-Child Pairs Cohort collected from April 10, 2016, to April 30, 2018. Group-based trajectory modeling was used to classify fasting plasma glucose levels during pregnancy into 3 glycemic trajectories (trajectory 1, consistently normal glucose levels in all 3 trimesters; trajectory 2, hyperglycemia only in late pregnancy; and trajectory 3, hyperglycemia in all 3 trimesters [ie, consistently high glucose levels]). Statistical analysis was performed from April 25, 2020, to October 1, 2021. EXPOSURES Gestational diabetes, which was defined using the results of an oral glucose tolerance test. MAIN OUTCOMES AND MEASURES Longitudinal fetal biometrics during gestational weeks 11 to 40 and birth outcomes were obtained from medical records. Pregnancy was partitioned into 3 periods (<24, 24-34, and >34 weeks' gestational age). The differences in offspring growth (log-transformed) and maternal glucose levels were compared using generalized linear mixed models. RESULTS A total of 4121 pregnant women had oral glucose tolerance test results (mean [SD] age, 28.8 [4.1] years), 3746 of whom had glycemic trajectory data (mean [SD] age, 28.6 [4.1] years); 983 women (23.8%) had gestational diabetes. Throughout the pregnancy period and compared with the women without gestational diabetes or with women in the trajectory 1 group, the fetal biometrics for the women with gestational diabetes or for those in the trajectory 3 group were significantly higher (except for bi parietal diameter), with an estimated increase in fetal weight in the group with gestational diabetes (beta = 1.82; 95% CI, 1.03-2.61) and in the trajectory 3 group (beta = 1.50; 95% CI, 0.54-2.47; P = .002). Fetal biometric alterations among women with gestational diabetes appeared before 24 weeks' gestational age, with neonatal birth weight significantly higher than in the group without gestational diabetes at 40.4 g (95% CI. 9.8-71.1 g) along with an increased risk of large size for gestational age (odds ratio, 1.36; 95% CI, 1.05-1.75) and macrosomia (odds ratio, 1.47; 95% CI, 1.12-1.94). However, pregnant women in the trajectory 2 group manifested significantly reduced fetal biometrics, and abdominal circumference was significantly augmented after 34 weeks' gestational age (increase, beta = 1.92; 95% CI. 0.87-2.99). CONCLUSIONS AND RELEVANCE In this cohort study, pregnant women who received a diagnosis of gestational diabetes in midpregnancy or had hyperglycemia during all 3 trimesters showed an association with altered fetal growth patterns, including increased estimated fetal weight that appeared before 24 weeks' gestational age, increased birth weight, and the risk for large size for gestational age and macrosomia.

Associations between maternal urinary kisspeptin in late pregnancy and decreased fetal growth: a pregnancy-birth cohort study

Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China

Gestational Exposure to Bisphenol Analogues and Kisspeptin Levels in Pregnant Women and Their Children: A Pregnancy-Birth Cohort Study.

Kisspeptin As a Potential Biomarker Throughout Pregnancy

Association Between Maternal Blood Lipids Levels During Pregnancy and Risk of Small-for-gestational-age Infants.

Effect of Maternal Lipid Profile, C-peptide, Insulin, and HBA1c Levels During Late Pregnancy on Large-for-gestational Age Newborns

Urinary biomarker of late pregnancy exposure to drinking water disinfection by-products and ultrasound measures of fetal growth in Wuhan, China

Effect of maternal sleep in late pregnancy on leptin and lipid levels in umbilical cord blood

Associations between maternal early pregnancy depression and longitudinal fetal growth

Associations of Longitudinal Fetal Growth Patterns With Cardiometabolic Factors at Birth

Longitudinal Associations Between Maternal Glucose Levels and Ultrasonographic Fetal Biometrics in a Shanghai Cohort

Observations Of The Effects Of Maternal Fasting Plasma Glucose Changes In Early Pregnancy On Fetal Growth Profiles And Birth Outcomes

Associations of maternal dietary patterns during pregnancy and fetal intrauterine development

Measurement of Fetal Abdominal and Subscapular Subcutaneous Tissue Thickness During Pregnancy to Predict Macrosomia: a Pilot Study.

The Expression and Significance of Kisspeptins in Plasma and Placenta of Early Pregnancy

Maternal fasting glucose levels throughout the pregnancy and risk of adverse birth outcomes in newborns: a birth cohort study in Foshan city, Southern China

Early pregnancy fasting plasma glucose and lipid concentrations in pregnancy and association to offspring size: a retrospective cohort study

Blood Pressure in Early and Mid-Pregnancy and the Risk of Small-for-gestational-age Birth: Findings of a Large Cohort Study in China

Role of serum kisspeptin as a biomarker to detect miscarriage: a systematic review and meta-analysis

The Impact of Maternal Stress on Offspring Birth Weight and the Mediating Effect of Dietary Patterns: the Shanghai Maternal-Child Pairs Cohort Study.

Maternal Lipid Profile During Early Pregnancy and Birth Weight: A Retrospective Study